GlassScriptPhysician profile
Jonathan Ty Butler
NPI 1770873879
$822.01
in general payments reported to CMS, 2019-2025
14 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.99 · 2020: $12.29 · 2021: $147 · 2022: $96.73 · 2023: $23.11 · 2024: $315 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $250.11 | 2019-2025 | Vumerity |
| Insightec,INC | $171.21 | 2024 | Exablate |
| Abbvie INC. | $74.80 | 2022-2025 | |
| Allergan, INC. | $67.39 | 2021 | |
| Pfizer INC. | $55.00 | 2022 | |
| Lundbeck LLC | $31.27 | 2025 | Vyepti |
| Medtronic, INC. | $29.59 | 2021 | |
| Horizon Therapeutics Plc | $26.33 | 2021 | |
| Tg Therapeutics, INC. | $23.11 | 2023 | |
| Alexion Pharmaceuticals, INC. | $21.61 | 2019 | |
| Cycle Pharmaceuticals INC | $21.60 | 2024 | Tascenso Odt |
| Genzyme Corporation | $17.45 | 2019 | |
| Csl Behring | $17.42 | 2025 | Hizentra |
| Novartis Pharmaceuticals Corporation | $15.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.